现金管理

Search documents
新中港: 关于使用闲置自有资金进行现金管理的公告
Zheng Quan Zhi Xing· 2025-08-25 16:52
Group 1 - The company has approved the use of up to RMB 300 million of idle self-owned funds for cash management, with a usage period not exceeding 12 months [1][2] - The purpose of cash management is to enhance the efficiency of idle funds, increase cash asset returns, and maximize shareholder benefits while ensuring normal operations and manageable risks [1][2] - The investment products will include high-security, good liquidity, and principal-protected options such as structured deposits, agreement deposits, notice deposits, fixed-term deposits, and large-denomination certificates of deposit [1][2] Group 2 - The resolution is valid for 12 months from the date of approval by the board of directors [2] - The management team is authorized to make investment decisions and sign relevant documents, with the finance department responsible for implementation [2] - The company will fulfill its information disclosure obligations in accordance with the regulations of the Shanghai Stock Exchange [2] Group 3 - The use of idle funds for cash management is expected to improve the efficiency of self-owned funds and increase company revenue, aligning with the interests of the company and its shareholders without affecting the development of its main business [2]
新中港: 第三届监事会第十次会议决议公告
Zheng Quan Zhi Xing· 2025-08-25 16:52
Group 1 - The company held a supervisory board meeting on August 25, 2025, with all three supervisors present, complying with relevant laws and regulations [1] - The meeting approved the 2025 semi-annual report, confirming that the report's content and format meet regulatory requirements and accurately reflect the company's financial status and operational results [1] - The meeting also approved the special report on the use of raised funds, confirming compliance with regulations and that there were no violations in the use of these funds [2] Group 2 - The company approved the use of up to 300 million RMB of idle self-owned funds for cash management to enhance the efficiency of fund usage and increase cash asset returns [3]
科前生物: 武汉科前生物股份有限公司2025年半年度募集资金存放与实际使用情况的专项报告
Zheng Quan Zhi Xing· 2025-08-25 16:31
Core Viewpoint - The report provides a detailed account of Wuhan Keqian Biological Co., Ltd.'s fundraising activities, including the total amount raised, usage of funds, and management practices, ensuring compliance with regulatory requirements [1][2][3][4][5] Fundraising Overview - The company raised a total of RMB 1,227.45 million through the issuance of 105 million shares at a price of RMB 11.69 per share, with net proceeds amounting to RMB 1,158.26 million after deducting underwriting fees [1] - As of December 31, 2024, the cumulative amount invested from the raised funds was RMB 854.01 million, leaving a balance of RMB 337.87 million [1][2] Fund Usage and Management - The company has established a dedicated account for managing the raised funds, adhering to the "Three-party Supervision Agreement" with the bank and sponsor to ensure proper usage [1][2] - As of June 30, 2025, the company had directly invested RMB 89.23 million into fundraising projects and incurred a total of RMB 5.20 million in handling fees [2][3] Cash Management - The company has utilized idle funds for cash management, achieving a total return of RMB 13.42 million from interest and investment income [1][3][5] - The total amount of idle funds managed was RMB 365 million, with a cash management balance of RMB 230 million as of June 30, 2025 [5] Project Changes - The company terminated the "Animal Biological Product Workshop Technical Renovation Project" and redirected the remaining funds of RMB 287.14 million to the "High-level Animal Vaccine Industrialization Base Construction Project (Phase I)" [4][5] - The decision to change the project was approved by the board and the supervisory committee, ensuring compliance with regulatory requirements [4][5] Fund Usage Reporting - The report includes detailed tables showing the usage of raised funds, with a total of RMB 94.32 million invested in various projects by the end of the reporting period [4][5] - The company has not encountered any issues in disclosing the usage of funds, maintaining transparency in accordance with regulatory guidelines [4]
天禄科技: 监事会决议公告
Zheng Quan Zhi Xing· 2025-08-25 16:20
Meeting Overview - The third meeting of the Supervisory Board of Suzhou Tianlu Technology Co., Ltd. was held on August 25, 2025, with all three supervisors present [1] - The meeting was convened in accordance with relevant laws, regulations, and the company's articles of association [1] Financial Report Review - The Supervisory Board reviewed the 2025 semi-annual report and its summary, concluding that they accurately reflect the company's operational status for the first half of 2025 without any false records or omissions [1][2] - The voting result for the report was unanimous, with 3 votes in favor and no opposition or abstentions [2] Fund Usage Report - The Supervisory Board approved the special report on the storage and usage of raised funds for the first half of 2025, confirming its accuracy and compliance with regulations [2] - The voting result for the fund usage report was also unanimous, with 3 votes in favor [2] Asset Impairment Provision - The Supervisory Board agreed that the provision for asset impairment was in line with relevant guidelines and accurately reflects the company's financial status [2][3] - The voting result for the asset impairment provision was unanimous, with 3 votes in favor [3] Non-operating Fund Occupation - The Supervisory Board confirmed that there were no non-operating fund occupations by controlling shareholders or related parties as of June 30, 2025 [3] - The voting result for this review was unanimous, with 3 votes in favor [3] Cash Management of Idle Funds - The Supervisory Board approved the use of part of the idle raised funds for cash management, stating it would enhance fund efficiency without harming the interests of the company or its shareholders [3] - The voting result for the cash management decision was unanimous, with 3 votes in favor [3]
中旗股份: 关于使用自有资金进行现金管理的公告
Zheng Quan Zhi Xing· 2025-08-25 16:20
Core Viewpoint - Jiangsu Zhongqi Technology Co., Ltd. plans to use idle self-owned funds not exceeding RMB 200 million for cash management by purchasing low-risk financial products to enhance fund utilization efficiency and return on investment [1][3]. Investment Overview - Investment Subject: The company and its subsidiaries [1]. - Investment Purpose: To rationally utilize idle self-owned funds for investment management [1]. - Investment Limit: Total investment in financial products will not exceed RMB 200 million, with funds being able to be rolled over within this limit [1][2]. Investment Characteristics - Investment Types: Focus on high safety, good liquidity, and low-risk financial products, excluding stocks, derivatives, securities investment funds, and other related investment types [2]. - Investment Duration and Authorization: Valid for one year from the date of board approval, with the chairman authorized to make investment decisions and sign relevant contracts [2]. - Source of Funds: Idle self-owned funds from the company and its subsidiaries [2]. - No Related Party Transactions: The company and its subsidiaries have no related relationships with the financial institutions providing the financial products [2]. Risk Control Measures - The financial manager is responsible for organizing the implementation, with the finance department handling specific operations [3]. - The company will analyze and monitor the investment products and take necessary measures to control investment risks if adverse factors are identified [3]. Impact on the Company - Utilizing idle self-owned funds for low-risk financial product investments will enhance the company's fund utilization efficiency and return on investment, without adversely affecting its production and operations [3][4]. Decision-Making Process - Board Approval: The cash management proposal was unanimously approved by all directors [3]. - Supervisory Board Approval: The supervisory board also agreed to the proposal, ensuring that it does not harm the interests of the company and its shareholders, especially minority shareholders [3].
凯伦股份: 董事会决议公告
Zheng Quan Zhi Xing· 2025-08-25 16:19
Group 1 - The board of directors of Jiangsu Kairun Building Materials Co., Ltd. held its 19th meeting on August 25, 2025, with all 6 attending members, confirming compliance with relevant laws and regulations [1] - The board approved the 2025 semi-annual report and its summary, affirming the report's authenticity and completeness [2] - The board also approved a special report on the management and use of raised funds, confirming compliance with regulations and no harm to shareholder interests [2] Group 2 - The board approved the provision for asset impairment, aligning with accounting standards and reflecting the company's financial status as of June 30, 2025 [3] - A proposal for conducting futures hedging for raw materials was approved, with a maximum margin of RMB 10 million for a 12-month period [3] - The board agreed to nominate Chen Xianfeng as a non-independent director, pending approval at the shareholders' meeting [4] Group 3 - The board approved the appointment of Chen Jie as the vice general manager and board secretary, effective until the end of the current board's term [5] - A proposal to use up to RMB 80 million of idle funds for cash management in low-risk financial products was approved, with a 12-month usage period [5] - The board approved a guarantee for the operating needs of its subsidiaries, ensuring compliance with regulations and manageable risk [6] Group 4 - The board approved amendments to the company's articles of association to enhance governance and compliance with updated regulations [6] - The board approved the establishment, revision, and abolition of certain governance systems [7] - A proposal to hold the second extraordinary general meeting of shareholders in 2025 on September 11 was approved [8]
海昌新材: 2025年半年度募集资金存放与使用情况的专项报告
Zheng Quan Zhi Xing· 2025-08-25 16:13
Core Viewpoint - The company provided a detailed report on the usage and management of raised funds from its initial public offering, highlighting the total amount raised, expenses incurred, and the allocation of funds to various projects [1][2]. Fundraising Overview - The company raised a total of RMB 379.4 million by issuing 20 million shares at RMB 18.97 each, with net proceeds amounting to RMB 344 million after deducting issuance costs of RMB 35.4 million [1]. - As of June 30, 2025, the total amount of raised funds used was RMB 189.97 million, with a remaining balance of RMB 28.27 million [2][5]. Fund Management - The company established a dedicated fund management system in compliance with relevant laws and regulations, including a tripartite supervision agreement with banks to ensure proper storage and usage of the raised funds [1][2]. - The balance of the raised funds in dedicated bank accounts was RMB 27.31 million in demand deposits and RMB 28 million in structured deposits as of June 30, 2025 [2][7]. Project Funding and Usage - The company allocated funds to two main projects: the construction of a 4,000-ton high-grade powder metallurgy component project and a technology renovation project for powder metallurgy new materials, with a total investment of RMB 243.31 million [5][6]. - As of June 30, 2025, the company had used RMB 148.30 million for the first project and RMB 25.43 million for the second project, resulting in a total surplus of RMB 89.75 million from both projects [6][7]. Surplus Fund Management - The company decided to permanently supplement its working capital with the surplus funds from the completed projects, totaling RMB 89.75 million, and planned to close the related dedicated fund accounts [6][7]. - The company has also utilized idle raised funds for cash management, generating a return of RMB 22.92 million from investments in safe and liquid financial products [2][6]. Compliance and Reporting - The company confirmed that all disclosures regarding the usage of raised funds were timely, accurate, and complete, adhering to the regulatory requirements set by the Shenzhen Stock Exchange [8].
科威尔技术股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-24 18:08
Group 1 - The company reported a total of RMB 75,880.00 million raised from its initial public offering (IPO) with a net amount of RMB 68,955.19 million after deducting issuance costs [5][32] - As of June 30, 2025, the company has utilized RMB 1,587.80 million from the IPO funds directly for investment projects and earned RMB 957.73 million in net interest and investment income [3][4] - The remaining balance of the IPO funds is RMB 25,001.86 million, which includes RMB 6,001.86 million in the special account and RMB 19,000.00 million in idle funds [3][4] Group 2 - In 2023, the company raised RMB 18,830.26 million through a targeted issuance of shares, with a net amount of RMB 18,342.53 million after deducting issuance costs [5][33] - By June 30, 2025, the company has used RMB 2,568.79 million from the targeted issuance for investment projects and earned RMB 173.77 million in net interest and investment income [5][6] - The remaining balance from the targeted issuance is RMB 6,651.10 million, including RMB 3,651.10 million in the special account and RMB 3,000.00 million in idle funds [5][6] Group 3 - The company has established a management system for the raised funds to ensure compliance with relevant regulations and to enhance the efficiency of fund usage [6][8] - The company has signed tripartite supervision agreements with its underwriters and banks to regulate the responsibilities and obligations of all parties involved in the management of the raised funds [7][10] - The company has not experienced any significant changes in its operational status or any major events that would impact its financial situation during the reporting period [3][12] Group 4 - The company plans to use up to RMB 23,000 million of temporarily idle raised funds for cash management, ensuring that it does not affect the progress of investment projects [31][39] - The cash management will involve investing in safe, liquid, and guaranteed-return financial products, including structured deposits and certificates of deposit [39][41] - The company has received no objections from its underwriter regarding the cash management plan, confirming that it complies with relevant regulations [47][48]
振东制药: 董事会决议公告
Zheng Quan Zhi Xing· 2025-08-24 16:16
证券代码:300158 证券简称:振东制药 公告编号:2025-044 山西振东制药股份有限公司 一、董事会会议召开情况 山西振东制药股份有限公司(以下简称"公司")第六届董事会第 四次会议于 2025 年 8 月 22 日上午 9:00 在公司会议室通过现场及通 讯表决方式召开,会议通知于 2025 年 8 月 12 日以电话、邮件等方式 通知全体董事。会议应出席董事 9 名,实际出席董事 9 名。会议由公 司董事长李昆先生主持,公司全体监事及高级管理人员列席了会议。 本次会议的出席人数、召集、召开程序和议事内容均符合国家有关法 律、法规及《公司章程》的规定。 二、董事会会议审议情况 年半年度报告>及其摘要》。 《2025 年半年度报告》及《2025 年半年度报告摘要》内容详见 中国证监会创业板指定信息披露网站。 本议案已由董事会审计委员会审议并通过。 及其子公司使用自有资金进行现金管理的议案》。 本着股东利益最大化原则,为提高资金的使用效率,在确保不影 响公司正常经营以及保证流动性和资金安全的前提下,公司董事会同 意公司及公司子公司使用额度不超过人民币 10 亿元的自有资金进行 现金管理,并授权管理层在上 ...
振东制药: 监事会决议公告
Zheng Quan Zhi Xing· 2025-08-24 16:13
Group 1 - The sixth meeting of the supervisory board of Shanxi Zhendong Pharmaceutical Co., Ltd. was held on August 22, 2025, with all three supervisors present, confirming compliance with legal and regulatory requirements [1] - The supervisory board reviewed the 2025 semi-annual report and found that the report accurately reflects the company's actual situation without any false statements or omissions [1] - The semi-annual report and its summary are available on the designated information disclosure website of the China Securities Regulatory Commission [1] Group 2 - The supervisory board approved the proposal for the company and its subsidiaries to use up to RMB 1 billion of idle self-owned funds for cash management, focusing on low to medium-risk financial products [2] - The decision to utilize idle funds is aimed at improving capital efficiency and cash management returns, aligning with the interests of the company and all shareholders, particularly minority shareholders [2] - The cash management proposal complies with relevant regulations and does not involve high-risk investment products as defined by the Shenzhen Stock Exchange [2]